Cargando…
Effective Achievement of Hemoglobin Stability with Once-Monthly C.E.R.A. in Peritoneal Dialysis Patients: A Prospective Study
BACKGROUND: Correction of low hemoglobin (Hb) levels is associated with improved survival and greater quality of life in dialysis patients, but frequent administration of erythropoiesis stimulating agent (ESA) therapy is unsatisfactory for peritoneal dialysis patients. OBJECTIVE: The objective of th...
Autores principales: | Koch, Michael, Treiber, Wolfgang, Fliser, Danilo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3775191/ https://www.ncbi.nlm.nih.gov/pubmed/23975657 http://dx.doi.org/10.1007/s40261-013-0091-z |
Ejemplares similares
-
Once-Monthly Continuous Erythropoietin Receptor Activator (C.E.R.A.) in Patients with Hemodialysis-Dependent Chronic Kidney Disease: Pooled Data from Phase III Trials
por: Locatelli, Francesco, et al.
Publicado: (2016) -
C.E.R.A. maintains stable hemoglobin in Latin American patients on dialysis
por: Bastos, Kleyton, et al.
Publicado: (2012) -
C.E.R.A. once every 4 weeks corrects anaemia and maintains haemoglobin in patients with chronic kidney disease not on dialysis
por: Roger, Simon D., et al.
Publicado: (2011) -
Once-monthly continuous erythropoietin receptor activator (CERA) for haemoglobin maintenance in haemodialysis patients with chronic renal anaemia
por: Duman, Neval, et al.
Publicado: (2014) -
Persona di cera/
por: Tynianov, IU. N. 1894-1943 (IUrii Nikolaevich)